We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PerkinElmer Completes Acquisition of Pediatrix's Newborn Metabolic Screening Business
News

PerkinElmer Completes Acquisition of Pediatrix's Newborn Metabolic Screening Business

PerkinElmer Completes Acquisition of Pediatrix's Newborn Metabolic Screening Business
News

PerkinElmer Completes Acquisition of Pediatrix's Newborn Metabolic Screening Business

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "PerkinElmer Completes Acquisition of Pediatrix's Newborn Metabolic Screening Business"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

PerkinElmer, Inc., a global leader in Health Sciences, today announced that it has successfully completed its acquisition of the newborn metabolic screening business of Pediatrix Medical Group, Inc. The completion of this transaction expands PerkinElmer's capabilities in the neonatal health field.

PerkinElmer has added Pediatrix's screening reference laboratory and its StepOne(R) newborn screening product, which is capable of analyzing more than 50 inherited disorders in newborns, to its genetic screening product offerings. The laboratory provides neonatal screening and consultative services to five states and the District of Columbia, as well as to hospitals and medical groups.

"Our strategy is for PerkinElmer to enhance its capability to deliver a growing portfolio of world-class neonatal and prenatal/maternal health solutions to consumers through their healthcare professionals," said Robert F. Friel, Chief Executive Officer and President of PerkinElmer. "With the completion of this acquisition, we now can provide state laboratories with the most comprehensive array of newborn screening solutions available and strengthen our leadership in this growing market."

Advertisement